Product image of Ervebo (Recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine (Live)) supplied by GNH India

Ervebo

Active Ingredient:
Recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine (Live)
Origin:
EU

Ervebo (Recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine (Live))

Ervebo is a recombinant vaccine designed to prevent Ebola virus disease caused by Zaire ebolavirus. It is administered intramuscularly and is manufactured by Merck Sharp & Dohme B.V.

Manufacturer / TM Owner

Merck Sharp & Dohme B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ervebo is used to provide protection against Ebola virus disease, specifically the Zaire ebolavirus strain. This vaccine is intended for individuals at risk of exposure to the virus, such as healthcare workers and those in outbreak areas. The primary use of Ervebo is to stimulate the immune system to produce antibodies against the Ebola virus.

Side Effects

  • Common effects of Ervebo may include mild to moderate reactions at the injection site, such as pain, swelling, or redness. Some individuals may experience general symptoms like fatigue, headache, or muscle pain. These effects are typically temporary and resolve on their own.

Precautions & Warnings

  • Ervebo should be administered by healthcare professionals trained in the use of vaccines. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Pregnant women and individuals with weakened immune systems should consult their healthcare provider before vaccination.

Avoid Interactions

  • There are no specific interactions widely reported with Ervebo. However, it is always advisable to inform your healthcare provider about any medications or supplements you are taking before receiving the vaccine. This helps ensure the safety and effectiveness of the vaccination process.

Frequently Asked Questions

Ervebo is used to prevent Ebola virus disease caused by the Zaire ebolavirus strain.

Ervebo is administered intramuscularly, typically in the upper arm.

Ervebo is intended for individuals at risk of exposure to the Ebola virus, such as healthcare workers and those in outbreak areas.

Common side effects may include pain, swelling, or redness at the injection site, as well as fatigue, headache, or muscle pain.

Pregnant women should consult their healthcare provider before receiving the Ervebo vaccine.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine (Live)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT